The next few years will likely see the evaluation in the clinic of new immune-based combinations..." "To further optimize outcome, combination strategies are needed to overcome tumor evasion.
No takes yet. Share an insight, caveat, or question.
Ulahannan et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: